| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/08/2013 | CN103083494A Traditional Chinese medicine for treating vascular headache |
| 05/08/2013 | CN103083490A Traditional Chinese medicine for treating post-traumatic brain syndrome |
| 05/08/2013 | CN103083458A Warm light drink compound formula granule, as well as preparation method as well as detection method thereof |
| 05/08/2013 | CN103083456A Traditional Chinese medicine composition for treating migraine |
| 05/08/2013 | CN103083451A Traditional Chinese medical ointment for treating shoulder-hand syndrome as well as preparation method thereof |
| 05/08/2013 | CN103083438A Method for treating insomnia by using traditional Chinese medicine |
| 05/08/2013 | CN103083432A Drug for treating hemiplegia and preparation method of drug |
| 05/08/2013 | CN103083421A Anti-anxiety and sleep promoting medicine composition |
| 05/08/2013 | CN103083408A Composition of traditional Chinese medicine extracts, and preparation method and application thereof |
| 05/08/2013 | CN103083400A Drug for treating cardiovascular disease |
| 05/08/2013 | CN103083395A Preparation method of lamiophlomis rotate dry extract |
| 05/08/2013 | CN103083318A Bilayer tablet comprising telmisartan and amlodipine |
| 05/08/2013 | CN103083317A Compound medicine and preparation method thereof |
| 05/08/2013 | CN103083315A Traditional Chinese medicine component composition and uses thereof |
| 05/08/2013 | CN103083306A Application of salvianolic acid A composition in preparing medicines for inhibiting brain tissue neuron damage or death |
| 05/08/2013 | CN103083305A Salvianolic acid A composition and application thereof in preparing medicines |
| 05/08/2013 | CN103083304A Application of salvianolic acid A composition for preparing medicines for preventing and/or treating cerebral thrombosis |
| 05/08/2013 | CN103083303A Application of salvianolic acid A composition in preparing medicines for improving neural function symptom after cerebral ischemia |
| 05/08/2013 | CN103083302A Application of salvianolic acid A composition in preparing medicines for protecting ischemic brain tissue damage |
| 05/08/2013 | CN103083300A Application of salvianolic acid A composition in preparing medicines for protecting cerebrovascular endothelial cells |
| 05/08/2013 | CN103083299A Salvianolic acid A composition and application thereof in preparing medicines |
| 05/08/2013 | CN103083298A Application of salvianolic acid A composition in preparing medicines for protecting ischemic brain tissue damage |
| 05/08/2013 | CN103083297A Application of salvianolic acid A composition in preparing medicines for improving neural function symptom after cerebral ischemia |
| 05/08/2013 | CN103083296A Application of salvianolic acid A composition in preparing medicines for protecting cerebrovascular endothelial cells |
| 05/08/2013 | CN103083295A Application of salvianolic acid A freeze-dried powder injection in preparing medicines for improving neural function symptom after cerebral ischemia |
| 05/08/2013 | CN103083294A Application of salvianolic acid A freeze-dried powder injection in preparing medicines for protecting ischemic brain tissue damage |
| 05/08/2013 | CN103083293A Demethylated venlafaxine benzoate compound clathrate and preparation method thereof |
| 05/08/2013 | CN103083288A Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
| 05/08/2013 | CN103083287A Application of iIllicium macranthum alcohol in preparation of medicine for treating depression |
| 05/08/2013 | CN103083274A Slow-release composition containing L-milnacipran and preparation method thereof |
| 05/08/2013 | CN103083272A Levetiracetam bioadhesive sustained-release tablet and preparation method thereof |
| 05/08/2013 | CN103083257A Salvianolic acid A freeze-dried powder injection and application thereof for preparing medicines |
| 05/08/2013 | CN103083255A Purpose of salvianolic acid A freeze-dried powder injection for preparing medicine for inhibiting brain tissue neuron damage or death |
| 05/08/2013 | CN103083237A Lipid emulsion of magnolol and preparation method thereof |
| 05/08/2013 | CN103083235A Myricetin nanosuspension and preparation method thereof |
| 05/08/2013 | CN103083232A Edaravone injection without antioxidant and preparation method thereof |
| 05/08/2013 | CN103082399A Snuff and preparation method thereof |
| 05/08/2013 | CN103082285A Nutritional health-care product for preventing encephalatrophy |
| 05/08/2013 | CN102757471B Novel active cytidine disodium triphosphate compound and pharmaceutical composition thereof |
| 05/08/2013 | CN102579806B Drug combination for treating schizophrenia |
| 05/08/2013 | CN102429931B Compound fermented cordyceps fungus powder salvianic acid combined drug |
| 05/08/2013 | CN102370934B Chinese medicinal preparation for enhancing memory and preparation method thereof |
| 05/08/2013 | CN102321007B Oxiracetam compound and preparation method as well as medicine composition thereof |
| 05/08/2013 | CN102274296B Application of tenuigenin in preparing medicament for preventing or treating parkinson' disease (PD) |
| 05/08/2013 | CN102274195B Oxiracetam freeze-dried powder preparation and preparation method thereof |
| 05/08/2013 | CN102266433B Application of winter jasmine in preparing medicines for treating acute spinal cord injury |
| 05/08/2013 | CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
| 05/08/2013 | CN102190708B Barrel-shaped alpha conantokin Bt1.3 and application thereof |
| 05/08/2013 | CN102174362B Siberian solomonseal rhizome health-care wine and preparation method thereof |
| 05/08/2013 | CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/08/2013 | CN102047995B Kudzuvine flower health tea and preparation method thereof |
| 05/08/2013 | CN102020638B 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 05/08/2013 | CN101906039B Hydroxyl acid ester compound of substituted phenol, preparation method and application in drug |
| 05/08/2013 | CN101827816B Therapeutic agent for TRPV1-mediated disease |
| 05/08/2013 | CN101823970B Synthetic method of rivastigmine and intermediates thereof |
| 05/08/2013 | CN101801955B Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 05/08/2013 | CN101801907B Compounds isolated from antrodia cinnamomea and use thereof |
| 05/08/2013 | CN101744917B Applications of Chinese medicinal composition to preparation of medicament for improving hypertension nervous symptoms |
| 05/08/2013 | CN101528221B Use of azabicyclo hexane derivatives |
| 05/08/2013 | CN101400703B Domain antibody construct |
| 05/08/2013 | CN101355946B Compounds for modulating TRPV3 function |
| 05/07/2013 | USRE44205 Adenosine A2a receptor antagonists |
| 05/07/2013 | US8436021 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 05/07/2013 | US8436019 Sulfonyl-piperidin-4-yl methylamine amide analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 05/07/2013 | US8436017 Beta-2-adrenoreceptor agonists |
| 05/07/2013 | US8436006 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 05/07/2013 | US8435949 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
| 05/07/2013 | US8435945 GH secretagogues and uses thereof |
| 05/07/2013 | US8435564 Pharmaceutical compositions comprising brivaracetam |
| 05/07/2013 | US8435534 Cancer immunotherapy |
| 05/07/2013 | CA2744932C Nalmefene hydrochloride dihydrate |
| 05/07/2013 | CA2694911C Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 05/07/2013 | CA2615121C Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
| 05/07/2013 | CA2590349C Potentiators of glutamate receptors |
| 05/07/2013 | CA2575081C Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2013 | CA2574827C 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2013 | CA2438032C Benzothiazole derivative compounds, compositions and uses |
| 05/02/2013 | WO2013063549A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | WO2013063309A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy |
| 05/02/2013 | WO2013063120A2 Nmda receptor modulators and uses thereof |
| 05/02/2013 | WO2013063086A1 Compositions and methods for treatment of proteinopathies |
| 05/02/2013 | WO2013062680A1 Novel compounds and compositions thereof for treating nervous system disorders |
| 05/02/2013 | WO2013062444A1 Peptide azemiopsin selectively interacting with nicotinic acetylcholine receptors of muscle type |
| 05/02/2013 | WO2013062079A1 Dihydroimidazooxazole derivative |
| 05/02/2013 | WO2013062074A1 Imidazolone derivative |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013061279A1 Uses of indole-ketones or indolidones as neuro-protective drugs |
| 05/02/2013 | WO2013061106A1 Modified peptide toxins |
| 05/02/2013 | WO2013060715A1 Use of filipendula extracts for the prophylaxis and treatment of extrapyramidal motor disorders |
| 05/02/2013 | WO2013060668A1 New therapy for transthyretin-associated amyloidosis |
| 05/02/2013 | WO2013060636A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 05/02/2013 | WO2013060258A1 Clavatine a-c, preparation method thereof and pharmaceutical composition and use thereof |
| 05/02/2013 | WO2013060097A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |
| 05/02/2013 | WO2013060029A1 Allosteric modulators of metabotropic glutamate receptors |
| 05/02/2013 | WO2013036015A3 Azetidine derivative and antidepressant composition containing same |
| 05/02/2013 | WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| 05/02/2013 | WO2012084126A3 Formulation of lacosamide |
| 05/02/2013 | US20130109755 Baclofen Formulations and Methods for Making Same |
| 05/02/2013 | US20130109719 Method of treating attention deficit disorders with d-threo methylphenidate |